Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998WO1998048027A2 Materials and methods for treatment of retinal diseases
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998048009A2 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998WO1998047898A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047875A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
10/29/1998WO1998047869A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998WO1998047509A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998WO1998047498A1 Neuroprotective compounds and uses thereof
10/29/1998WO1998047365A1 Methods for reducing fibrinogen
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998WO1998009953A3 Azinyloxy-and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
10/29/1998CA2288292A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents
10/29/1998CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998CA2287508A1 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998CA2287495A1 Materials and methods for treatment of retinal diseases
10/29/1998CA2287255A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998CA2287196A1 Methods for reducing fibrinogen
10/29/1998CA2287162A1 Neuroprotective compounds and uses thereof
10/29/1998CA2286865A1 Edg-1-like receptor
10/29/1998CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998CA2286673A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998CA2286108A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
10/29/1998CA2286106A1 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998EP0873404A1 Angiotensin converting enzyme inhibitors
10/28/1998EP0873357A2 Antithrombotic agents and methods of use
10/28/1998EP0873340A1 Heterocyclic substituted cyclopentane compounds
10/28/1998EP0873335A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873301A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0873131A1 Vasodilating composition
10/28/1998EP0873128A1 Oral administration of effective amounts of forms of hyaluronic acid
10/28/1998EP0873124A1 A method of treating hypercholesterolemia and related disorders
10/28/1998EP0873123A1 Inhibitors of protein isoprenyl transferases
10/28/1998EP0873051A1 Modulation of calcium channels
10/28/1998EP0759742B1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
10/28/1998EP0716648B1 New 9-chloro-prostaglandin derivatives
10/28/1998EP0712406B1 Condensed indole derivatives as 5-ht 4-receptor antagonists
10/28/1998EP0649418B1 7-(2-aminoethyl)-benzothiazolones
10/28/1998CN1197452A Azetidinone derivatives for treatment of atherosclerosis
10/28/1998CN1197450A Esters and amides as PLA2 inhibitors
10/28/1998CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998CN1197072A New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
10/28/1998CN1196954A Compound ginkgo leaf prepn. and its prepn. method
10/28/1998CN1040435C Trisubstituted biphenyls, its prepn. and applications in medicines
10/27/1998US5827897 Insulin-resistance in a mammal treated by administering a synergistic mixture of a retinoid and a fatty acid; antidiabetic agents
10/27/1998US5827893 Mechanical and pharmacological therapies to treat cardiac arrest
10/27/1998US5827892 Treatment and prevention of atherosclerosis
10/27/1998US5827890 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
10/27/1998US5827880 Salen-metal complexes
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827868 Prostaglandin analogs
10/27/1998US5827863 Pyrazole derivatives as angiotensin II antagonists
10/27/1998US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998US5827844 Having an n-pyrrolidinyl or n-piperidinyl group
10/27/1998US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998US5827536 Anticholesterol drug solution comprising a solubilizer nonionic surfactant diethylene glycol monoethyl ether
10/24/1998CA2228743A1 Novel integrin ligand itgl-tsp
10/22/1998WO1998046731A1 Inhibitors for urokinase receptor
10/22/1998WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998WO1998046632A2 Inhibitors for urokinase receptor
10/22/1998WO1998046628A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046627A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046626A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046605A1 5,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds and their use as adenosine kinase inhibitors
10/22/1998WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998WO1998046589A2 Indazole amide compounds as serotoninergic agents
10/22/1998WO1998046585A1 Inhibitors of cholesterol esterase
10/22/1998WO1998046572A1 Imidazole and imidazoline derivatives and uses thereof
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046237A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998WO1998046076A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
10/22/1998WO1998031399A3 Labelled factor xiiia substrates
10/22/1998WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998CA2286909A1 5,7-disubstituted 4-aminopyrido¬2,3-d|pyrimidine compounds and their use as adenosine kinase inhibitors
10/22/1998CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998CA2286332A1 Inhibitors for urokinase receptor
10/22/1998CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998CA2285705A1 Selective factor xa inhibitors
10/22/1998CA2285685A1 Selective factor xa inhibitors
10/22/1998CA2285659A1 Selective factor xa inhibitors
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998CA2284525A1 Inhibitors of cholesterol esterase
10/22/1998CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
1 ... 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 ... 1595